China Viscosupplementation Market Size & Outlook, 2025-2033

The viscosupplementation market in China is expected to reach a projected revenue of US$ 656.5 million by 2033. A compound annual growth rate of 6.7% is expected of China viscosupplementation market from 2025 to 2033.
Revenue, 2024 (US$M)
$355.4
Forecast, 2033 (US$M)
$656.5
CAGR, 2025 - 2033
6.7%
Report Coverage
China

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

China viscosupplementation market, 2021-2033 (US$M)

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

China viscosupplementation market highlights

  • The China viscosupplementation market generated a revenue of USD 355.4 million in 2024 and is expected to reach USD 656.5 million by 2033.
  • The China market is expected to grow at a CAGR of 6.7% from 2025 to 2033.
  • In terms of segment, single injection was the largest revenue generating product in 2024.
  • Single Injection is the most lucrative product segment registering the fastest growth during the forecast period.


Viscosupplementation market data book summary

Market revenue in 2024USD 355.4 million
Market revenue in 2033USD 656.5 million
Growth rate6.7% (CAGR from 2025 to 2033)
Largest segmentSingle injection
Fastest growing segmentSingle Injection
Historical data2021 - 2023
Base year2024
Forecast period2025 - 2033
Quantitative unitsRevenue in USD million
Market segmentationSingle Injection, Three Injection, Five Injection
Key market players worldwideDePuy Synthes, Sanofi SA, Smith & Nephew PLC, Anika Therapeutics Inc, Zimmer Biomet Holdings Inc, Ferring, Lifecore Biomedical Inc, LG Chem, Roche Holding AG


Other key industry trends

  • In terms of revenue, China accounted for 6.7% of the global viscosupplementation market in 2024.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
  • In Asia Pacific, Japan viscosupplementation market is projected to lead the regional market in terms of revenue in 2033.
  • Australia is the fastest growing regional market in Asia Pacific and is projected to reach USD 117.3 million by 2033.

Single injection was the largest segment with a revenue share of 48.54% in 2024. Horizon Databook has segmented the China viscosupplementation market based on single injection, three injection, five injection covering the revenue growth of each sub-segment from 2021 to 2033.


According to an article published in Forbes magazine in 2017, China was the fastest aging country in the world, with a projection of 44% geriatric population by 2050. The aging population in the country is aggravating healthcare burden, especially pertaining to treatment of age-related diseases. The risk of osteoporosis is higher in people who are over 50 years.

In the year 2013, the population falling under this group was around 357 million. In 2013, the country had more than 85 million osteoarthritis patients. By 2025, total population of osteoporosis patients is expected to reach 1.39 billion in which more than 518 million are anticipated to be over 50.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Viscosupplementation Market Companies

Name Profile # Employees HQ Website
Lifecore Biomedical Inc View profile 459 3515 Lyman Boulevard, Chaska, MN, United States, 55318 https://www.lifecore.com
Ferring View profile 5001-10000 Saint-prex, Vaud, Switzerland, Europe https://www.ferring.com
Anika Therapeutics Inc View profile 357 32 Wiggins Avenue, Bedford, MA, United States, 01730 https://www.anika.com
LG Chem View profile 10001+ Seoul, Seoul-t'ukpyolsi, South Korea, Asia https://www.lgchem.com
Smith & Nephew PLC View profile 18452 Hatters Lane, Building 5, Croxley Park, Watford, Hertfordshire, United Kingdom, WD18 8YE https://www.smith-nephew.com
DePuy Synthes View profile 5001-10000 Raynham, Massachusetts, United States, North America https://depuysynthes.com
Zimmer Biomet Holdings Inc View profile 18000 345 East Main Street, Warsaw, IN, United States, 46580 https://www.zimmerbiomet.com
Roche Holding AG View profile 103605 Grenzacherstrasse 124, Basel, Switzerland, 4070 https://www.roche.com
Sanofi SA View profile 87994 46, avenue de la Grande Armée, Paris, France, 75017 https://www.sanofi.com

China viscosupplementation market size, by product, 2021-2033 (US$M)

China Viscosupplementation Market Outlook Share, 2024 & 2033 (US$M)

China viscosupplementation market size, by product, 2021-2033 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more
Chat with us
Research Assistance
Online